Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Pacific Kansas City Limited Common Shares vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.5 (market cap $73.98B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 5.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.9% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| CP | HALO | |
|---|---|---|
Market Cap | $73.98B | $12.58B |
Volume | 1,669,828 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $96.69 | $115.22 |
52-Week Low | $68.88 | $61.63 |
Enterprise Value | $91.36B | $14.49B |
Dividend Yield | 0.9% | — |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canadian Pacific Kansas City Limited Common Shares
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
